Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Primary Osteoarthritis Companies

Primary osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage in the joints. Companies involved in primary osteoarthritis may focus on the development of pharmaceuticals, medical devices, and treatments aimed at managing the symptoms and progression of this condition.

Primary Osteoarthritis Key Companies Latest Primary Osteoarthritis Companies Update

Sep 2023: Government documents reveal that the state of Goa in India has notified Abbott Laboratories' local business (ABT.N) that it intends to revoke the license to manufacture its antacid medication after inspectors discovered contamination concerns and sanitization problems at the factory. The American pharmaceutical business is embroiled in a battle with drug inspectors in the western Indian state of Goa, a popular vacation destination. The company voluntarily recalled numerous batches of Digene Gel syrup made in Goa beginning in August after receiving customer complaints regarding its taste and odor. The health of the patient is unaffected, according to Abbott. Healthcare data indicates that Digene holds a 7% market share for so-called antiflatulent drugs in India, where Abbott operates two factories: Goa and Hyderabad.

Nov 2023: The US Food and Drug Administration (FDA) has approved Astellas Pharma Inc. and Pfizer Inc.'s supplementary New Drug Application for the small-molecule medication Xtandi (enzalutamide). The companies made this announcement. Based on the findings of the phase 3 Embark trial, the FDA expedited development and review processes. With this approval, Xtandi becomes the first and sole androgen receptor signaling inhibitor authorized by the FDA for the treatment of individuals with biochemically driven recurrence of high-risk prostate cancer (high-risk BCR) who have nonmetastatic castration-sensitive prostate cancer (nmCSPC). Xtandi may be used in combination with gonadotropin-releasing hormone (GnRH) analog treatment for patients with nmCSPC and high-risk BCR.List of Primary Osteoarthritis Key companies in the market

Abbott Laboratories (U.S.)

Johnson & Johnson Limited (U.S.)

Novartis AG (Switerzland)

Pfizer, Inc. (U.S.)

Eli Lilly and Company (U.S.)

Abiogen Pharma (Italy)

Ampio pharmaceuticals (U.S.)

BioDelivery Sciences International (U.S.)

CrystalGenomics (South Korea)

Daiichi Sankyo (Japan)

Eli Lilly (U.S.)

Horizon Pharma (Republic of Ireland)

Iroko Pharmaceuticals (U.S.)

Merck & Co. Ltd (U.S.)

Nuvo Research (U.S.)

Regeneus (Australia)

Sanofi (France)

SantoSolve (U.S.)

Smith & Nephew (UK)

Winston Pharmaceuticals (India).

Primary Osteoarthritis Market Highlights:

Primary Osteoarthritis Market Size

Primary Osteoarthritis Market Trends

Primary Osteoarthritis Market Analysis

Primary Osteoarthritis Market Share

Primary Osteoarthritis Market Highlights:

Primary Osteoarthritis Market Trends

Primary Osteoarthritis Market Analysis

Primary Osteoarthritis Market Share

Primary Osteoarthritis Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.